权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Lactate transporter MCT1 is required for the high suppressive function of tumor infiltrating regulatory T cells

肿瘤浸润调节性 T 细胞的高抑制功能需要乳酸转运蛋白 MCT1

基本信息

批准号：
9908825
负责人：
McLane Watson
金额：
$ 4.55万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-02-01 至 2022-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9908825
关键词：
Address Amino Acids Autoimmunity Biological Assay CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes CD8B1 gene Carbon Cell Differentiation process Cell Line Cell Respiration Cell physiology Cells Cellular Metabolic Process Citric Acid Cycle Clonal Expansion Colorectal Cancer Communication Data Environment Eragrostis Exhibits FOXP3 gene Genus Hippocampus Glucose Glycolysis Homeostasis Hypoxia Immune In Vitro Interferon Type II Isotopes Knock-out Knowledge Lactate Transporter Lactic acid Link Lymphoid Tissue Malignant Neoplasms Measures Melanoma Cell Metabolic Metabolism Methods Modeling Mus Patients Peripheral Phenotype Positioning Attribute Postdoctoral Fellow Production Propionates Regulatory T-Lymphocyte Research Research Personnel Role Shapes T cell differentiation Testing Training Tumor Immunity Tumor-infiltrating immune cells Volatile Fatty Acids cancer immunotherapy conditioning cytotoxic effector T cell feeding genetic signature glucose uptake gut microbiota improved knock-down melanoma metabolic profile migration neoplastic cell prevent programmed cell death protein 1 recruit resistance mechanism skills success systemic autoimmunity therapy design transcription factor tumor tumor growth tumor metabolism tumor microenvironment tumor progression

项目摘要

Lactate transporter MCT1 is required for the high suppressive function of tumor infiltrating regulatory T cells Abstract Cancer immunotherapy has revolutionized the way we treat cancer, but most patients fail to respond due to several resistance mechanisms including the recruitment, proliferation, and differentiation of regulatory T (Treg) cells in the tumor microenvironment (TME). While cytotoxic effector T (Teff) cells are rendered dysfunctional by the TME, the natural immunosuppressive function of Treg cells remains intact. Treg and Teff cells exhibit distinct metabolisms which may explain the discrepancy in their function within the TME. Metabolically, the TME is characterized by hypoxia, low pH, and limiting metabolites such as glucose and amino acids. While the highly glycolytic Teff cells are in direct competition with the tumor for glucose, recent evidence suggests Foxp3, the lineage defining transcription factor of Treg cells, can reprogram metabolism of Treg cells to function in high lactate, low glucose environments. Hypothesizing that Treg cells were supported by lactic acid within the TME, we bred a mouse with a Treg specific deletion of the lactate transporter MCT1 (Slc16a1f/f Foxp3YFPCre) and inoculated them with B16 melanoma. Treg specific loss of MCT1 resulted in slowed tumor growth and increased survival without leading to systemic autoimmunity. Measuring lactic acid concentration, we observed high levels within B16 tumors relative to peripheral lymphoid tissues. While MCT1 is predominantly recognized to transport lactate, it has several other substrates, such as propionate and studies on colonic Treg cells suggest propionate enhances Treg cell function and differentiation. Preliminary data from our lab corroborate these results, showing Treg cells conditioned in propionate increased expression of Treg markers Nrp1 and Helios. However, from these observations two questions arise, 1) is MCT1 required for Treg cell function only in lactate high TMEs, and 2) how do non-lactate MCT1 substrates influence Treg cell metabolism? We hypothesize that MCT1 is required for intratumoral Treg cell function in lactate rich TMEs and that its substrates promote an oxidative metabolism and the expression of Treg cell signature genes. To address this hypothesis, first we will (1) determine the requirement of MCT1 for intratumoral Treg cell function in metabolically distinct TMEs. We will inoculate Slc16a1f/f Foxp3YFPCre mice with metabolically distinct melanoma cell lines and measure the impact on intratumoral Treg cell metabolism via Seahorse, and function via suppression assay. Second, we will (2) determine the impact of non-lactate MCT1 substrate propionate on Treg cell metabolism. Using Foxp3YFPCre mice we will isolate Treg cells then condition them in media containing propionate and measure the impact on metabolism via Seahorse and apply isotopic flux analysis to identifying how Treg cells utilize propionate. By understanding the role of MCT1 and its substrates for Treg cell metabolism and function we can better design therapies that specifically dampen intratumoral Treg cells and improve cancer immunotherapies. This training will prepare me for an academic post-doctoral and ultimately independent investigator position by enhancing my research and communication skills and deepening my knowledge of Treg cells in cancer.